Genetics of acquired long QT syndrome
- PMID: 16075043
- PMCID: PMC1180553
- DOI: 10.1172/JCI25539
Genetics of acquired long QT syndrome
Abstract
The QT interval is the electrocardiographic manifestation of ventricular repolarization, is variable under physiologic conditions, and is measurably prolonged by many drugs. Rarely, however, individuals with normal base-line intervals may display exaggerated QT interval prolongation, and the potentially fatal polymorphic ventricular tachycardia torsade de pointes, with drugs or other environmental stressors such as heart block or heart failure. This review summarizes the molecular and cellular mechanisms underlying this acquired or drug-induced form of long QT syndrome, describes approaches to the analysis of a role for DNA variants in the mediation of individual susceptibility, and proposes that these concepts may be generalizable to common acquired arrhythmias.
Figures
Similar articles
-
Molecular predictors of drug-induced prolongation of the QT interval.Curr Med Chem Cardiovasc Hematol Agents. 2005 Apr;3(2):105-18. doi: 10.2174/1568016053544318. Curr Med Chem Cardiovasc Hematol Agents. 2005. PMID: 15853698 Review.
-
The inherited long QT syndrome: from ion channel to bedside.Cardiol Rev. 1999 Jan-Feb;7(1):44-55. Cardiol Rev. 1999. PMID: 10348966 Review.
-
Cellular mechanisms of Torsade de Pointes.Novartis Found Symp. 2005;266:204-17; discussion 217-24. Novartis Found Symp. 2005. PMID: 16050270 Review.
-
The molecular genetics of the long QT syndrome: genes causing fainting and sudden death.Annu Rev Med. 1998;49:263-74. doi: 10.1146/annurev.med.49.1.263. Annu Rev Med. 1998. PMID: 9509262 Review.
-
Acquired QT interval prolongation and HERG: implications for drug discovery and development.Eur J Pharmacol. 2004 Oct 1;500(1-3):129-42. doi: 10.1016/j.ejphar.2004.07.019. Eur J Pharmacol. 2004. PMID: 15464027 Review.
Cited by
-
Cardiovascular precision medicine - A pharmacogenomic perspective.Camb Prism Precis Med. 2023 Jun 29;1:e28. doi: 10.1017/pcm.2023.17. eCollection 2023. Camb Prism Precis Med. 2023. PMID: 38550953 Free PMC article. Review.
-
Psychotherapeutic drug-induced life-threatening arrhythmias: A retrospective analysis using the Japanese adverse drug event report database.J Arrhythm. 2023 Oct 3;39(6):928-936. doi: 10.1002/joa3.12936. eCollection 2023 Dec. J Arrhythm. 2023. PMID: 38045460 Free PMC article.
-
Interpretable Machine Learning Prediction of Drug-Induced QT Prolongation: Electronic Health Record Analysis.J Med Internet Res. 2022 Dec 1;24(12):e42163. doi: 10.2196/42163. J Med Internet Res. 2022. PMID: 36454608 Free PMC article.
-
Drug-Induced QT Prolongation and Torsade de Pointes in Spontaneous Adverse Event Reporting: A Retrospective Analysis Using the Japanese Adverse Drug Event Report Database (2004-2021).Drugs Real World Outcomes. 2022 Dec;9(4):551-559. doi: 10.1007/s40801-022-00328-0. Epub 2022 Aug 22. Drugs Real World Outcomes. 2022. PMID: 35994235 Free PMC article.
-
Effects of azithromycin on ventricular repolarization in children with COVID-19.Rev Port Cardiol. 2022 Jul;41(7):551-556. doi: 10.1016/j.repc.2021.04.008. Epub 2022 Feb 21. Rev Port Cardiol. 2022. PMID: 35221464 Free PMC article.
References
-
- Viskin S, Justo D, Halkin A, Zeltser D. Long QT syndrome caused by noncardiac drugs. Prog. Cardiovasc. Dis. 2003;45:415–427. - PubMed
-
- Roden DM. Drug-induced prolongation of the QT Interval. N. Engl. J. Med. 2004;350:1013–1022. - PubMed
-
- Dessertenne F. La tachycardie ventriculaire à deux foyers opposés variables. Arch. Mal. Coeur Vaiss. 1966;59:263–272. - PubMed
-
- Halkin A, et al. Pause-dependent torsade de pointes following acute myocardial infarction. A variant of the acquired long QT syndrome. J. Am. Coll. Cardiol. 2001;38:1168–1174. - PubMed
-
- Schwartz PJ, Wolf S. QT interval prolongation as a predictor of sudden death in patients with myocardial infarction. Circulation. 1978;56:1074–1077. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical